FDA testing Nestle’s Maggi noodles after India recall

Published June 12, 2015
A spokeswoman for the Swiss-based company said the United States’ FDA was now also looking into the issue. -AFP/File
A spokeswoman for the Swiss-based company said the United States’ FDA was now also looking into the issue. -AFP/File

ZURICH: The US Food and Drug Administration (FDA) is testing samples of a Nestle instant noodle brand that was recalled from stores across India last week, a spokeswoman for the Swiss food group said on Thursday.

Nestle, the world’s largest food company, is seeking to defend its reputation in India after it pulled Maggi instant noodles from stores following reports by regulators that some packets contained excess lead.

A spokeswoman for the Swiss-based company said the United States’ FDA was now also looking into the issue. “We have been made aware that the FDA has taken samples of Maggi noodles manufactured in India from third-party importers’ containers for testing, and we have asked the importers to advise us of the outcome of the FDA tests,” the spokeswoman said in an emailed statement.

Nestle challenges India ban

Meanwhile, the company said on Thursday it is challenging a ban imposed by India.

Nestle said it had approached the high court in Mumbai seeking a judicial review of a June 5 order from the government’s food safety regulator banning the product.

“Nestle India Limited has today approached the Hon’ble Bombay High Court raising issues of interpretation of the Food Safety and Standards Act 2011,” said a statement posted on the company’s website.

Published in Dawn, June 12th, 2015

On a mobile phone? Get the Dawn Mobile App: Apple Store | Google Play

Follow Dawn Business on Twitter, LinkedIn, Instagram and Facebook for insights on business, finance and tech from Pakistan and across the world.

Opinion

Editorial

IMF’s projections
Updated 18 Apr, 2024

IMF’s projections

The problems are well-known and the country is aware of what is needed to stabilise the economy; the challenge is follow-through and implementation.
Hepatitis crisis
18 Apr, 2024

Hepatitis crisis

THE sheer scale of the crisis is staggering. A new WHO report flags Pakistan as the country with the highest number...
Never-ending suffering
18 Apr, 2024

Never-ending suffering

OVER the weekend, the world witnessed an intense spectacle when Iran launched its drone-and-missile barrage against...
Saudi FM’s visit
Updated 17 Apr, 2024

Saudi FM’s visit

The government of Shehbaz Sharif will have to manage a delicate balancing act with Pakistan’s traditional Saudi allies and its Iranian neighbours.
Dharna inquiry
17 Apr, 2024

Dharna inquiry

THE Supreme Court-sanctioned inquiry into the infamous Faizabad dharna of 2017 has turned out to be a damp squib. A...
Future energy
17 Apr, 2024

Future energy

PRIME MINISTER Shehbaz Sharif’s recent directive to the energy sector to curtail Pakistan’s staggering $27bn oil...